Cargando…

Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study

BACKGROUND: The increasing group of melanoma survivors reports multiple unmet needs regarding survivorship care (SSC). To optimise melanoma SSC, it is crucial to take into account the perspectives of oncological healthcare providers (HCPs) in addition to those of patients. The aim of this study is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamminga, Nadia C. W., Wakkee, Marlies, De Bruin, Rianne J., van der Veldt, Astrid. A. M., Joosse, Arjen, Reeder, Suzan W. I., Plaisier, Peter W., Nijsten, Tamar, Lugtenberg, Marjolein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042579/
https://www.ncbi.nlm.nih.gov/pubmed/36973713
http://dx.doi.org/10.1186/s12885-023-10759-9
_version_ 1784912964394942464
author Kamminga, Nadia C. W.
Wakkee, Marlies
De Bruin, Rianne J.
van der Veldt, Astrid. A. M.
Joosse, Arjen
Reeder, Suzan W. I.
Plaisier, Peter W.
Nijsten, Tamar
Lugtenberg, Marjolein
author_facet Kamminga, Nadia C. W.
Wakkee, Marlies
De Bruin, Rianne J.
van der Veldt, Astrid. A. M.
Joosse, Arjen
Reeder, Suzan W. I.
Plaisier, Peter W.
Nijsten, Tamar
Lugtenberg, Marjolein
author_sort Kamminga, Nadia C. W.
collection PubMed
description BACKGROUND: The increasing group of melanoma survivors reports multiple unmet needs regarding survivorship care (SSC). To optimise melanoma SSC, it is crucial to take into account the perspectives of oncological healthcare providers (HCPs) in addition to those of patients. The aim of this study is to gain an in-depth understanding of HCPs’ perspectives on appropriate melanoma SSC. METHODS: Four online focus groups were conducted with mixed samples of oncological HCPs (dermatologists, surgeons, oncologists, oncological nurse practitioners, support counsellors and general practitioners) (total n = 23). A topic guide was used to structure the discussions, focusing on perspectives on both SSC and survivorship care plans (SCPs). All focus groups were recorded, transcribed verbatim, and subjected to an elaborate thematic content analysis. RESULTS: Regarding SSC, HCPs considered the current offer minimal and stressed the need for broader personalised SSC from diagnosis onwards. Although hardly anyone was familiar with SCPs, they perceived various potential benefits of SCPs, such as an increase in the patients’ self-management and providing HCPs with an up-to-date overview of the patient’s situation. Perceived preconditions for successful implementation included adequate personalisation, integration in the electronic health record and ensuring adequate funding to activate and provide timely updates. CONCLUSIONS: According to HCPs there is considerable room for improvement in terms of melanoma SSC. SCPs can assist in offering personalised and broader i.e., including psychosocial SSC. Aside from personalisation, efforts should be focused on SCPs' integration in clinical practice, and their long-term maintenance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10759-9.
format Online
Article
Text
id pubmed-10042579
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100425792023-03-28 Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study Kamminga, Nadia C. W. Wakkee, Marlies De Bruin, Rianne J. van der Veldt, Astrid. A. M. Joosse, Arjen Reeder, Suzan W. I. Plaisier, Peter W. Nijsten, Tamar Lugtenberg, Marjolein BMC Cancer Research BACKGROUND: The increasing group of melanoma survivors reports multiple unmet needs regarding survivorship care (SSC). To optimise melanoma SSC, it is crucial to take into account the perspectives of oncological healthcare providers (HCPs) in addition to those of patients. The aim of this study is to gain an in-depth understanding of HCPs’ perspectives on appropriate melanoma SSC. METHODS: Four online focus groups were conducted with mixed samples of oncological HCPs (dermatologists, surgeons, oncologists, oncological nurse practitioners, support counsellors and general practitioners) (total n = 23). A topic guide was used to structure the discussions, focusing on perspectives on both SSC and survivorship care plans (SCPs). All focus groups were recorded, transcribed verbatim, and subjected to an elaborate thematic content analysis. RESULTS: Regarding SSC, HCPs considered the current offer minimal and stressed the need for broader personalised SSC from diagnosis onwards. Although hardly anyone was familiar with SCPs, they perceived various potential benefits of SCPs, such as an increase in the patients’ self-management and providing HCPs with an up-to-date overview of the patient’s situation. Perceived preconditions for successful implementation included adequate personalisation, integration in the electronic health record and ensuring adequate funding to activate and provide timely updates. CONCLUSIONS: According to HCPs there is considerable room for improvement in terms of melanoma SSC. SCPs can assist in offering personalised and broader i.e., including psychosocial SSC. Aside from personalisation, efforts should be focused on SCPs' integration in clinical practice, and their long-term maintenance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10759-9. BioMed Central 2023-03-28 /pmc/articles/PMC10042579/ /pubmed/36973713 http://dx.doi.org/10.1186/s12885-023-10759-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kamminga, Nadia C. W.
Wakkee, Marlies
De Bruin, Rianne J.
van der Veldt, Astrid. A. M.
Joosse, Arjen
Reeder, Suzan W. I.
Plaisier, Peter W.
Nijsten, Tamar
Lugtenberg, Marjolein
Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
title Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
title_full Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
title_fullStr Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
title_full_unstemmed Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
title_short Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
title_sort oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042579/
https://www.ncbi.nlm.nih.gov/pubmed/36973713
http://dx.doi.org/10.1186/s12885-023-10759-9
work_keys_str_mv AT kamminganadiacw oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy
AT wakkeemarlies oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy
AT debruinriannej oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy
AT vanderveldtastridam oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy
AT joossearjen oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy
AT reedersuzanwi oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy
AT plaisierpeterw oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy
AT nijstentamar oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy
AT lugtenbergmarjolein oncologicalhealthcareprovidersperspectivesonappropriatemelanomasurvivorshipcareaqualitativefocusgroupstudy